PARMAR KUSH sold 5.5% of their position (155.25K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.08M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/10/2026ACC: 0001664281-26-000004
Director10% Owner
Since Oct 2021
-155.25K
Net shares
Net seller
$1.08M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
155.25K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−10.49K
Price / share
$7.00
Trade value
$73.46K
% of position
0.4%
8/6/2026
2.85M→2.84M
Common Stock
Indirect
Shares
−52.32K
Price / share
$6.85
Trade value
$358.37K
% of position
1.8%
8/7/2026
2.84M→2.78M
Common Stock
Indirect
Shares
−92.44K
Price / share
$7.00
Trade value
$647.11K
% of position
3.3%
8/10/2026
2.78M→2.69M
Total
Net shares
−155.25K
Net value
-$1.08M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/6/2026 | S · Sale | −10.49K | $7.00 | $73.46K | 0.4% | 2.85M | 2.84M |
| Common Stock Indirect | 8/7/2026 | S · Sale | −52.32K | $6.85 | $358.37K | 1.8% | 2.84M | 2.78M |
| Common Stock Indirect | 8/10/2026 | S · Sale | −92.44K | $7.00 | $647.11K | 3.3% | 2.78M | 2.69M |
| Total | −155.25K | -$1.08M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.09M
Total
1.09M indirect1.09M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.09M | Indirect |
| Total | 1.09M | 1.09M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported